In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Marconi, OGS form Confirmant to deliver gene data

Executive Summary

Marconi has created a joint venture with Oxford GlycoSciences (drug discovery based on genomics and proteomics) called Confirmant Ltd. to integrate Marconi's broadband data transmission and hosting abilities into OGS's proteome databases, specifically its Protein Atlas of the Human Proteome and data analysis software. The human proteome database is expected to provide pharma companies with real-time information on genes that encode for proteins. This data will then be used to develop products to diagnose and treat patients.
Deal Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Includes Royalty or Profit Split Information
    • Joint Venture

Related Companies